Rodrigo Carlessi retweeted
LIVER CANCER BIOMARKERS, RISK PREDICTION & PROGRESSION
With
Dr Rodrigo Carlessi @rodcarlessi, Senior Research Fellow & Lead of Cancer Genomics Group, Curtin Medical Research Institute @CurtinMRI, Curtin University @CurtinUni, Perth, Western Australia
RESEARCHER PROFILE
Filmed in Perth, Australia | August 2025
Dr. Rodrigo Carlessi is an expert in Cancer Genomics and Molecular Biology, with an extensive track record in liver cancer research. He leads the Cancer Genomics Group within the Liver Disease and Regeneration Laboratory at the Curtin Medical Research Institute. He has an impressive publication record, with 43 manuscripts that have collectively garnered over 2,680 citations. His research leverages cutting-edge genomics and transcriptomics technologies, as well as long-read DNA sequencing, to explore mechanisms, identify biomarkers, and develop therapeutic targets in liver disease and cancer.
Dr Carlessi graduated from the Federal University of Rio Grande do Sul (UFRGS) @ufrgsnoticias , Brazil, with a BSc. in Cellular and Molecular Biology in 2007, then joined the Weizmann Institute of Science @weizmannscience, Israel, where he obtained a MSc. from the Department of Molecular Genetics in 2011. He further obtained a PhD in Molecular Endocrinology from UFRGS in 2016, prior to joining Curtin University in Western Australia as a postdoc in 2016. He undertook postdoctoral training in pancreatic beta cell biology and received awards from the Australian Diabetes Society and the Heart Foundation. In 2019 he was recruited to start and lead the Cancer Genomics group in the Liver Disease & Regeneration Laboratory. With nine years of postdoctoral experience, Dr Carlessi has held a prestigious Cancer Council of Western Australia Postdoctoral Research Fellowship from 2021 to 2024.
His recent work led to a groundbreaking discovery in liver cancer risk prediction, earning him national and international recognition, following publications in top tier journals including Cell Genomics, Science Advances and Nature between 2023-2025. This achievement has been highlighted by invitations to present at prominent events, including Oz Single Cell, the Australian Liver Cancer Experts Gallipoli Meeting, WYMM Melbourne 2025, the First International Conference of Liver Pathobiology: From Bench to Bedside in Crete (2023), and the Thomas Ashworth Symposium 2025. His work has also catalysed collaborations with prestigious global institutions, such as The University of Edinburgh, the University of California San Diego, Monash University, and the University of New South Wales.
Currently, Dr. Carlessi focuses on discovering novel biomarkers and developing innovative approaches to assess risk and monitor disease progression in liver cancer patients. Additionally, he is pioneering RNA therapy technologies to target oncogenic pathways, paving the way for the next generation of liver cancer diagnostics and therapeutics.
Source: Supplied
SEE OTHER RESEARCHER PROFILES
Bench Side Story @BenchSideStory
benchsidestory.com
Get your own interviews and research published on Bench Side Story @BenchSideStory
benchsidestory.com/contact/
Rodrigo Carlessi retweeted
A review that is not to be missed! ✨
Dr. @BenjaminDwyer4 and @NinaTParker discuss state-of-the-art patient-derived liver #organoid models, recent technological advancements, and strategies to enhance their clinical impact. @CurtinUni
@Trends_Endo_Met | bit.ly/47nexgJ
Cancer Council WA's Daffodil Day is on Thursday 22 August! You can support ground-breaking cancer research projects like my own and help us unlock the answers to a cancer free future…Donate at bit.ly/3YAU4T0 @CancerCouncilWA
Looking forward to presenting our work at the Perth Nanopore Day today! #WYMM #LiverCancerCollaborative @NinaTParker @BenjaminDwyer4 @Anjali_Ghimire
8
285
Today is @CancerCouncilWA Daffodil Day – a chance to support vital cancer research projects like mine! tinyurl.com/2clq9q3p
Help us get closer to a cancer free future. Donate now at daffodilday.com.au. #DaffodilDay
1
6
274
Rodrigo Carlessi retweeted
New research from @CurtinUni’s Dr @rodcarlessi and Professor @NinaTParker has found identifying pre-malignant liver cells in patients with liver disease could help determine their future risk of developing #livercancer. Read more at: https://teapaw.org/t.co/nL06C1iiw1
#CurtinResearch
Incredibly happy to share our @CellGenomics paper where we identify a disease-associated hepatocyte state (daHep). cell.com/cell-genomics/fullt…
@CHIRI_curtin @CurtinMedia
daHeps are absent in healthy livers but prevalent in liver diseases. They display an enhanced mutational burden and are likely a pre-malignant intermediary. We found that high daHep levels precede carcinogenesis and can predict a higher risk of liver cancer development.
1
1
161
We hope this discovery will pave the way for a new paradigm to predict liver cancer risk, improve timely diagnosis and save lives.
This was a huge collaborative effort, thank you to all involved.
@NinaTParker @FebbraioMark @Al__Forrest @ry_lister @OlynykJohn @ElinSGrayPhD
Rodrigo Carlessi retweeted
If you want to know more about our #organoid work, check this out from our fantastic funding partner @minderoo Featuring wonderful scientists @GayatriShirolk1 and @SaraPasic96
we develop HTP bioprinted PDOs for drug discovery using @InventiaLifeSci RASTRUM
It’s #worldcancerday and Dr @Benjamindwyer4 shares how growing a human ‘mini-liver’ from stem cells may reveal valuable clues to curing liver cancer.
Want to learn more? 🤓 We've got it here 👉 https://teapaw.org/t.co/TJ4CWRTfkE
Rodrigo Carlessi retweeted
Single Nucleus RNA Sequencing of Pre-Malignant Liver Reveals Disease-Associated Hepatocyte State with HCC Prognostic Potential biorxiv.org/cgi/content/shor… #bioRxiv
Rodrigo Carlessi retweeted
#Thanks @10xGenomics @mscienceaustnz for generously providing a 4-reaction library preparation kit for @caryn_elsegood’s project. @genomics_wa are so grateful. You made our day! @brettke55834184 #InThisTogether #wegotyourback
Rodrigo Carlessi retweeted
Happy to announce that our Cancer Research Trust funded collaborative cancer grant “Enabling advanced single cell cancer genomics in Western Australia” has been renewed for another 4 years. @TimoLassmann @ry_lister @ElinSGrayPhD @ElenaDenisenko9 @rodcarlessi @perth_meso_dr + more
Rodrigo Carlessi retweeted
Proud to win the overall best project in the #curtinnovation awards for 2021 for our liver cancer prestige biomarker project at Optus Stadium today with Nina Tirnitz-Parker and Rodrigo Carlessi - a couple of brilliant scientists.
Rodrigo Carlessi retweeted
Hey folk, Nina is an amazing researcher and a lovely person! Here's a great opportunity for a PhD in cancer research.
#ecrchat @ECRchat @firstphdchat
This Post is from an account that no longer exists. Learn more
Join us and help figuring out how to predict Liver Cancer
scholarships.curtin.edu.au/S…
This Post is from an account that no longer exists. Learn more
4
Rodrigo Carlessi retweeted
We are hiring a Postdoctoral fellow to collaborate with us on Oncofetal ecosystem & tumor evolution @SharmaaLab
Come work with us in beautiful Perth & work in the area of single cell genomics & spatial transcriptomics @PerkinsComms & @CurtinUni
Plz RT!!
staff.curtin.edu.au/job-vaca…
Rodrigo Carlessi retweeted
Thanks @CancerCouncilWA for supporting @CHIRI_curtin, @CurtinUni liver #cancer researcher @rodcarlessi with a Postdoctoral Fellowship. Contributing vital funds towards research aimed at early detection & screening of liver cancer, with @NinaTParker. More buff.ly/3iUxuOl
























